CN104381354A - 防治肿瘤的预拌粉 - Google Patents
防治肿瘤的预拌粉 Download PDFInfo
- Publication number
- CN104381354A CN104381354A CN201410806680.6A CN201410806680A CN104381354A CN 104381354 A CN104381354 A CN 104381354A CN 201410806680 A CN201410806680 A CN 201410806680A CN 104381354 A CN104381354 A CN 104381354A
- Authority
- CN
- China
- Prior art keywords
- dry powder
- different leaf
- flour
- leaf anise
- liquid extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013312 flour Nutrition 0.000 title claims abstract description 20
- 206010028980 Neoplasm Diseases 0.000 title abstract description 27
- 230000002265 prevention Effects 0.000 title abstract 4
- 239000000843 powder Substances 0.000 claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 34
- 235000008429 bread Nutrition 0.000 claims abstract description 13
- 108010068370 Glutens Proteins 0.000 claims abstract description 8
- 235000021312 gluten Nutrition 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 239000000811 xylitol Substances 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 7
- 229960002675 xylitol Drugs 0.000 claims abstract description 7
- 235000010447 xylitol Nutrition 0.000 claims abstract description 7
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 40
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 29
- 241000209140 Triticum Species 0.000 claims description 9
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 6
- 240000005373 Panax quinquefolius Species 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 240000009023 Myrrhis odorata Species 0.000 claims 6
- 201000011510 cancer Diseases 0.000 abstract description 7
- 239000012530 fluid Substances 0.000 abstract description 6
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 241000534059 Pimpinella diversifolia Species 0.000 abstract 4
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 240000004760 Pimpinella anisum Species 0.000 description 34
- 230000000694 effects Effects 0.000 description 9
- 201000007270 liver cancer Diseases 0.000 description 9
- 208000014018 liver neoplasm Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000003174 Brain Neoplasms Diseases 0.000 description 4
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 206010025323 Lymphomas Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 201000001275 rectum cancer Diseases 0.000 description 4
- 201000000498 stomach carcinoma Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000012180 bread and bread product Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000010037 flour treatment agent Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/02—Treatment of flour or dough by adding materials thereto before or during baking by adding inorganic substances
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/181—Sugars or sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
防治肿瘤的预拌粉；本发明涉及一种防治肿瘤的预拌粉；本发明提供了一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100重量份制成流浸膏后再冷冻粉碎成干粉。本发明利用中草药异叶茴芹制成防治肿瘤疾病的预拌粉，具有抗菌抗病毒、抑癌作用；不仅适用于普通消费者日常食用保健以预防肿瘤疾病，也适用于肿瘤患者的辅助保健。
Description
技术领域
本发明涉及一种防治肿瘤的预拌粉，尤其是一种配用中药异叶茴芹防治肿瘤的面包预拌粉。
背景技术
现有技术没有应用异叶茴芹配制防治肿瘤的预拌粉产品，如在专利号为 03154271.9的发明——面包营养预拌粉，该发明公开了一种面包营养预拌粉，它由按重量百分比计算的0.5-10％的谷朊粉，0.5-15％的麦苗微粉，0.5-10％的麦苗麦绿素粉，0.1-1％的面包改良剂，80-98％的小麦面粉组成；使用它生产出来的面包制品具有天然的淡绿色，在营养价值方面改善较为明显均衡，叶绿素、胡萝卜素、纤维素、维生素C和B族、钙、铁等含量高出普通面包近一倍以上；且面包体积大，表面光滑，组织结构均匀，弹性好，口感细腻，很好的克服了传统面包预拌粉营养素改善不均衡且制成的面包口感不细腻等缺陷；该发明一种预拌粉只是具有一般保健作用，口味单一、缺乏抗肿瘤保健功能。
发明内容
为了解决现有技术问题，本发明的目的是要提供一种防治肿瘤的预拌粉，不仅适用于普通消费者日常食用保健以预防肿瘤疾病，对于肿瘤患者病情的治疗也起保健辅助作用。
技术方案：一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100重量份制成流浸膏后再冷冻粉碎成干粉。
制备方法：生产这种预拌粉时，将各组分按比例混合，然后搅拌均匀即成。制作面包、蛋糕的工艺按照常规操作完成即可。
实验研究：证实异叶茴芹中药流浸膏对小鼠肝癌(H22)动物肝癌模型有明显的抑瘤作用；异叶茴芹中药流浸膏具有增强小鼠细胞免疫和体液免疫功能的作用，并对K562和A549细胞周期具有阻滞作用，对K562和HepG2细胞促进凋亡作用，在蛋白质水平和mRNA水平对K562细胞中促凋亡基因BAX均有上调作用，对K562细胞和HepG2细胞增殖和端粒酶基因的表达具有显著抑制作用，由此表明异叶茴芹具有明显的抗肿瘤作用。
实验方法：异叶茴芹流浸膏是用异叶茴芹按中药流浸膏制法制成异叶茴芹流浸膏。建立小鼠肝癌(H22)动物移植肿瘤模型，随机将小鼠分为正常组、模型组、阳性组、药物小、中、大剂量组并分别给药，实验结束后，进行抑瘤率、胸腺指数、脾指数、肿瘤组织病理等相关指标检测，结果：异叶茴芹流浸膏对荷瘤小鼠的肿瘤生长有明显抑制作用，低、中、高剂量组的抑瘤率分别为31.08%、42.36%和46.20%，呈现良好的量效关系。病理学观察显示，模型组肿瘤细胞生长旺盛，而各用药组则出现不同程度的肿瘤细胞坏死，结论：异叶茴芹流浸膏对小鼠肝癌(H22)动物肝癌模型有明显的抑瘤作用。
异叶茴芹按《保健食品检验与评价技术规范》（2003版）中“食品安全性毒理学评价试验”进行实验，结果表明急性毒性试验小鼠经口LD50＞20g/kg，属实际无毒，长期毒理学研究结果证实：异叶茴芹的大鼠30日喂养试验，未见试验动物出现中毒症状，大体解剖及组织观察未见异常病理改变。对大鼠体重、进食量、食物利用率、血象、血生化均无明显影响。异叶茴芹高剂量组雌、雄性动物的剂量为人体推荐剂量（60mg/kg BW/d）120倍。证实中草药异叶茴芹长期服用是安全无毒的。
临床验证，分实验组和对照组：实验组采用本发明的异叶茴芹流浸膏治疗三个疗程（90天）后，与对照组(采用化疗和放疗)治疗三个疗程后相比，采用本发明的异叶茴芹流浸膏治疗的实验组中晚期肿瘤治疗的总有效率为94.2％，对照组对中晚期肿瘤治疗的总有效率为65.8％，治疗组的总有效率明显高于对照组。
1、病例选择：选择符合中晚期肿瘤诊断标准的病例240例，病人随机分成两组，治疗组120例，其中男66例(肝癌16例、肺癌14例、胃癌13例、食道癌9例、脑瘤6例、直肠癌3例、恶性淋巴癌5例)，女54例(肝癌10例、肺癌10例、胃癌10例、食道癌8例、脑瘤5例、直肠癌6例、恶性淋巴癌5例)；年龄22～78岁，平均年龄50.1岁；病程3～18个月，平均9.2个月。对照组120例，其中男64例(肝癌11例、肺癌17例、胃癌10、直肠癌8例、膀胱癌6例、食道癌6例、脑瘤3例、恶性淋巴癌3例)，女56例(肝癌9例、肺癌10例、胃癌9例、直肠癌5例、食道癌6例、脑瘤3例、乳腺癌4例、***3例、卵巢癌3例、恶性淋巴癌4例)；年龄25～80岁，平均年龄51.3岁；病程3～18个月，平均8.9个月。两组资历基本一致，无显著性差异，具有可比性。
2、治疗组患者服用本发明的异叶茴芹流浸膏，成人口服一次10-15毫升，一日3次，30天为一疗程；连续服用90天。对照组采用化疗和放疗。
3、判断标准： 显效：肿瘤瘤体缩小5％以上，自觉症状明显改善，主要症状消失；有效：肿瘤瘤体缩小2～5％，临床症状明显改善； 改善：肿瘤瘤体维持原来大小，临床症状改善；无效：肿瘤瘤体继续增长及临床症状无改善或加重。
4、结果：服用本发明的治疗组中，显效：63例，有效30例，改善20例，无效7例，总有效率94.2％；对照组中显效45例，有效23例，改善10例，无效42例，总有效率65.0％；治疗组的总有效率明显高于对照组。
作为优化，本发明一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100份、灯芯草0.2-2份、黄芪5-10份、西洋参5-10份制成流浸膏后再冷冻粉碎成干粉。
异叶茴芹味辛、苦、微甘、性微温；归肺；胃、肝经。功能主治：散风宣肺、理气止痛、消积健脾、活血通经、除湿解毒。主感冒、咳嗽、百日咳、肺痨、肺痈、头痛、头痛、芽痛、脆胁痛、胃气痛、腹胀痛、缩阴冷痛、风湿关节痛、劳伤、骨劳、消化不良、食积、疳积、痧症、泻痢、黄疸、疟疾、***、痛经、经闭、乳肿、目翳、咽肿、痄腮、跌打损伤、湿疹、皮肤瘙痒、蛇虫伤。
灯芯草，微寒、甘、淡；归心、肺、小肠、膀胱经。功效主治：利水通淋、清心降火。
黄芪味甘、温，归心、肺、脾、肾经；功能主治：补气固表、利尿、托毒排脓、生肌敛疮。主治气短心悸、倦怠、乏力、自汗、盗汗、久泻、脱肛、子宫脱垂、体虚浮肿、慢性肾炎、痈疽难溃、或溃久不敛。黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿，增强心肌收缩力，调节血糖含量。黄芪不仅能扩张冠状动脉，改善心肌供血，提高免疫功能，而且能够延缓细胞衰老的进程。黄芪食用方便，可煎汤，煎膏，浸酒，入菜肴等。
西洋参味甘、微苦，凉。归心、肺、肾经。功能主治：补气养阴、清热生津。用于气虚阴亏、内热、咳喘痰血、虚热烦倦、消渴、口燥咽干。
本发明优点是：1、口味清新甘醇，增添了预拌粉的新口味。选用天然中草药异叶茴芹为原料，使用安全，利用中草药综合防治肿瘤，无明显毒副作用；实验证明异叶茴芹单味中药流浸膏具有抗菌抗病毒、抑癌作用；具有清除癌性毒素、提高机体抗癌的免疫功能。
2、优选方用异叶茴芹清热除湿解毒、理气止痛、消积健脾、活血通经；散风宣肺；提高免疫功能之功效，配伍灯芯草利水通淋、清心降火，黄芪补气益血、温阳利水、安神解毒等作用，和西洋参增补元气、补益脾肺、益气生津、安神养心、健脑益智作用。
3、本发明利用民间野菜异叶茴芹制成防治肿瘤疾病的预拌粉，具有抗菌抗病毒、抑癌作用；不仅适用于普通消费者日常食用保健以预防肿瘤疾病，也适用于肿瘤患者的辅助保健。
具体实施方式
实施例1：一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100重量份制成流浸膏后再冷冻粉碎成干粉。
制备方法：生产这种预拌粉时，将各组分按比例混合，然后搅拌均匀即成。
实施例2：一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100份、灯芯草0.2-2份、黄芪5-10份、西洋参5-10份制成流浸膏后再冷冻粉碎成干粉。
制备方法同实施例1。
Claims (2)
1.一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100重量份制成流浸膏后再冷冻粉碎成干粉。
2.一种防治肿瘤的预拌粉，由以下配料按重量百分比计组成：包括10-20％异叶茴芹流浸膏干粉、1-5％面筋粉、4-10％的木糖醇、0.5-3％的精盐、0.01-1％的面包粉改良剂、面粉加至百分百；所述异叶茴芹流浸膏干粉是用异叶茴芹100份、灯芯草0.2-2份、黄芪5-10份、西洋参5-10份制成流浸膏后再冷冻粉碎成干粉。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410806680.6A CN104381354A (zh) | 2014-12-23 | 2014-12-23 | 防治肿瘤的预拌粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410806680.6A CN104381354A (zh) | 2014-12-23 | 2014-12-23 | 防治肿瘤的预拌粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104381354A true CN104381354A (zh) | 2015-03-04 |
Family
ID=52599404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410806680.6A Pending CN104381354A (zh) | 2014-12-23 | 2014-12-23 | 防治肿瘤的预拌粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104381354A (zh) |
-
2014
- 2014-12-23 CN CN201410806680.6A patent/CN104381354A/zh active Pending
Non-Patent Citations (5)
| Title |
|---|
| 孔增科等: "《常用中药药理与临床应用》", 31 January 2005 * |
| 徐晓卫等: ""浙江产异叶茴芹叶挥发油化学成分研究"", 《中国药业》 * |
| 李宁等: "《全天然食物最养生》", 30 November 2013 * |
| 林崇良等: ""浙江异叶回芹花序挥发油化学成分的研究"", 《江西中医药》 * |
| 赵余庆等: "《食疗与保健食品原料功能因子手册》", 31 March 2013 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104543714A (zh) | 保健马铃薯速食粥 | |
| CN104432239A (zh) | 一种鲟鱼丸食品 | |
| CN104397749A (zh) | 防治肿瘤的鹌鹑肉肠 | |
| CN104489034A (zh) | 防治肿瘤的保健饼干 | |
| CN104473054A (zh) | 防治肿瘤的大米速食粥 | |
| CN104430775A (zh) | 防治肿瘤的保健蛋糕 | |
| CN104585793A (zh) | 一种罗非鱼丸食品 | |
| CN104381354A (zh) | 防治肿瘤的预拌粉 | |
| CN104489769A (zh) | 一种黑鱼丸食品 | |
| CN104473235A (zh) | 保健鳝鱼丸食品 | |
| CN104397748A (zh) | 保健火鸡肉肠 | |
| CN104522733A (zh) | 一种娃娃鱼丸食品 | |
| CN104397754A (zh) | 一种保健竹鼠肉肠 | |
| CN104522709A (zh) | 防治肿瘤的鸭肉肠 | |
| CN104397756A (zh) | 保健牛蛙肉肠 | |
| CN104543759A (zh) | 防治肿瘤的保健面条 | |
| CN104473053A (zh) | 防治肿瘤的红豆速食粥 | |
| CN104543715A (zh) | 防治肿瘤的荞麦速食粥 | |
| CN104472626A (zh) | 防治肿瘤的保健面包 | |
| CN104431798A (zh) | 防治肿瘤的玉米速食粥 | |
| CN104472815A (zh) | 防治肿瘤的保健咖啡 | |
| CN104473055A (zh) | 防治肿瘤的小米速食粥 | |
| CN104431797A (zh) | 防治肿瘤的高粱速食粥 | |
| CN104473035A (zh) | 防治肿瘤的保健馒头 | |
| CN104489752A (zh) | 防治肿瘤的保健蛋卷 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150304 |
|
| WD01 | Invention patent application deemed withdrawn after publication |